Jamie E. Barcombe

Jamie is commercially-minded and focuses on devising and implementing strategies that address business goals: he approaches prosecution and client counseling with a focus on obtaining enforceable rights, drawing on his experience in contentious matters. When the need to litigate arises, Jamie leverages his technical background, industry experience, and expertise in patentability. He is pragmatic yet creative, and prioritises what constitutes success for clients in each specific instance. Jamie’s blended practice is also an asset in advising clients on FTO matters, as he understands both European and UK patent prosecution, which enables him to advise on the anticipated path of pending applications. He is also experienced in how infringement and validity are each assessed by the English courts and the UPC.

Jamie has a background in pharmaceutical research and development (R&D) and biochemistry, with a particular focus on the fields of pharmaceuticals and clean tech. He regularly advises clients on clinical and pre-clinical products, including antibodies and nucleic acids, and provides counseling on second medical use patents and the implications of clinical trial disclosures on patentability. Jamie’s practice also spans gene sequencing and sustainable fuels, alongside synthetic materials, biological manufacturing, mechanical engineering, and the intersection of software and artificial intelligence (AI) with life sciences.

Jamie began his career working in R&D for a multinational pharmaceutical company. He also completed academic research investigating the delivery of therapeutic nucleotides before transitioning to intellectual property. Prior to joining Finnegan, Jamie worked at another large patent law firm in the UK. He had previously practiced IP and contract management for a world-leading animal health institute.